Table 1.
Distributions of parameters used in the risk assessment model generated with MCS.
Fig 1.
Calculated EDI for TCP considering the targeted population groups.
Table 2.
Estimated Daily Intake of the CPF and Hazard quotient values of chlorpyrifos exposure levels in pregnant women (n = 80).
Fig 2.
Cumulative distribution of the HQ of CPF using the guideline values suggested by A: Chronic Reference Dose (CRfDWHO), B: Acute Reference Dose (ARfDWHO), C: Chronic Reference Dose (CRfDUSEPA), D: Acute Reference Dose (ARfDUSEPA) (The result of Crystal Ball, HQ defined as a forecast, the trial number was 10,000).
Fig 3.
Sensitivity analysis of noncarcinogenic risk for pregnant women (the result of Crystal Ball, the trial number was 10,000).